What is Lutetium Lu 177 dotatate made from?

It is a radioconjugate composed of a somatostatinâanalog peptide (Tyr³âoctreotate, DOTAâTATE) chelated to the radioisotope lutetiumâ177.

Lutetium Lu 177 dotatate bulk supplier for pharma manufacturers

Lutetium Lu 177 Dotatate 7.4 GBq/ vial Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 7.4 GBq/ vial

Reference Brands: Lutathera (USA, EU)

Category: Oncology Cancer Care

Lutathera is a radiolabeled peptide receptor radionuclide therapy (PRRT) used to treat gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that express somatostatin receptors. It works by delivering targeted radiation directly to tumor cells, minimizing damage to surrounding healthy tissue. The therapy is administered via intravenous infusion under specialized medical supervision, usually in cycles of four doses spaced eight weeks apart.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Lutetium Lu 177 Dotatate — third party manufacturing & bulk supply

Lutetium Lu 177 Dotatate 7.4 GBq/ vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lutetium Lu 177 Dotatate is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lutetium Lu 177 Dotatate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lutetium Lu 177 Dotatate →

Back to Listing

Frequently Asked Questions

Lutetium Lu 177 dotatate is used to treat somatostatin receptor‑positive gastroenteropancreatic neuroendocrine tumors (GEP‑NETs) in adults and in children aged 12 years and older.

It is a radioconjugate composed of a somatostatin‑analog peptide (Tyr³‑octreotate, DOTA‑TATE) chelated to the radioisotope lutetium‑177.

The trade name is Lutathera.

It is manufactured by Advanced Accelerator Applications, a subsidiary of Novartis.

The generic name is Lutetium Lu 177 dotatate.

The brand name is Lutathera.

It is produced under Good Manufacturing Practice (GMP) by Advanced Accelerator Applications / Novartis, with facilities and supply chain managed internationally.